Walgreens Boots Alliance, Inc. (WBA) Debt to Assets Ratio: 0.42%
The debt to assets ratio for Walgreens Boots Alliance, Inc. (WBA) is 0.42% as of Saturday, June 13, 2026.
WBA Debt to Assets Ratio Metrics
DEBT TO ASSETS RATIO
0.42%
WBA Competitors' Debt to Assets Ratio
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | 0.42% |
| Baxter International Inc. (BAX) | $10.77B | 0.50% |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 0.43% |
| Tempus AI, Inc. (TEM) | $8.35B | 0.36% |
| Align Technology, Inc. (ALGN) | $12.52B | 0.02% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 0.14% |
| The Cooper Companies, Inc. (COO) | $13.24B | 0.22% |
| Solventum Corporation (SOLV) | $13.66B | 0.35% |
| Hims & Hers Health, Inc. (HIMS) | $5.98B | 0.59% |
| Hologic, Inc. (HOLX) | $16.97B | 0.29% |
Leverage Ratios Comparison
Debt/Assets
0.4%
Debt/Equity
3.23
Current Ratio
0.68
Interest Coverage
-29.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
- Debt/Assets: Shows % of assets funded by creditors (bounded 0-100%)
- Debt/Equity: Shows debt relative to shareholder investment (can exceed 100%)
- Both measure leverage but from different perspectives
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Walgreens Boots Alliance, Inc. Debt to Assets Ratio Formula & Definition
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Walgreens Boots Alliance, Inc. Debt to Assets Ratio FAQ
- What is the debt to assets ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The debt to assets ratio for WBA stock is 0.42%.
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth